Cargando…

Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer

OBJECTIVE: The oncoprotein, hepatitis B X-interacting protein (HBXIP), has been reported to play an important role in human malignancies. However, its functions in non-small cell lung cancer (NSCLC) are poorly understood. The goal of the present study was to identify the role of HBXIP in the regulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jun, Sun, Bei, Ruan, Xianhui, Hou, Xiukun, Zhi, Jingtai, Meng, Xiangrui, Zheng, Xiangqian, Gao, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877173/ https://www.ncbi.nlm.nih.gov/pubmed/33628588 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0098

Ejemplares similares

The oncoprotein HBXIP facilitates metastasis of hepatocellular carcinoma cells by activation of MMP15 expression
por: Zheng, Sen, et al.
Publicado: (2019)

The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer
por: Liu, Fabao, et al.
Publicado: (2015)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells
por: Yue, Lin, et al.
Publicado: (2013)

Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
por: Liu, Bowen, et al.
Publicado: (2018)

KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway
por: Zhang, Wei, et al.
Publicado: (2022)

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
por: Hou, Xiukun, et al.
Publicado: (2021)

ERK/MAPK signalling pathway and tumorigenesis
por: Guo, Yan-Jun, et al.
Publicado: (2020)

FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer
por: Qiu, Li, et al.
Publicado: (2020)

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway
por: Meng, Xiangrui, et al.
Publicado: (2020)

LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
por: Jiang, Tao, et al.
Publicado: (2020)

Germacrone Regulates HBXIP-Mediated Cell Cycle, Apoptosis and Promotes the Formation of Autophagosomes to Inhibit the Proliferation of Gastric Cancer Cells
por: Fang, Xing, et al.
Publicado: (2020)

Corrigendum to: LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
Publicado: (2021)

Targeting Aurora-A inhibits tumor progression and sensitizes thyroid carcinoma to Sorafenib by decreasing PFKFB3-mediated glycolysis
por: Jingtai, Zhi, et al.
Publicado: (2023)

Functional analysis and clinical significance of the isocitrate dehydrogenase 2 gene in papillary thyroid carcinoma
por: Zhang, Jun, et al.
Publicado: (2019)

The EBV-Encoded Oncoprotein, LMP1, Recruits and Transforms Fibroblasts via an ERK-MAPK-Dependent Mechanism
por: Davis, Alexandra M, et al.
Publicado: (2021)

The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients
por: Ruan, Lingjuan, et al.
Publicado: (2018)

Absence of ERK5/MAPK7 delays tumorigenesis in Atm(−/−) mice
por: Granados-Jaén, Alba, et al.
Publicado: (2016)

HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
por: Yang, Zhi, et al.
Publicado: (2020)

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib
por: Hu, Linfei, et al.
Publicado: (2022)

HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer
por: Wang, Yixuan, et al.
Publicado: (2017)

AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma
por: Li, Yiran, et al.
Publicado: (2015)

Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK–ERK pathway
por: Hu, Yingying, et al.
Publicado: (2016)

The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021)

Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer
por: Xie, Wenjun, et al.
Publicado: (2021)

Surgery and Radioactive Iodine Therapeutic Strategy for Patients Greater Than 60 Years of Age with Differentiated Thyroid Cancer
por: Tang, Tao, et al.
Publicado: (2022)

HBXIP activates the PPARδ/NF-κB feedback loop resulting in cell proliferation
por: Liu, Qian, et al.
Publicado: (2017)

Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients
por: Zheng, Xiangqian, et al.
Publicado: (2019)

Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway
por: Zhao, Zewei, et al.
Publicado: (2022)

Correction: AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma
por: Li, Yiran, et al.
Publicado: (2020)

The effects of HBXIP on the biological functions of tongue squamous cell carcinoma cells and correlation with PI3K/Akt
por: Meng, Xue, et al.
Publicado: (2020)

MiR‐145‐targeted HBXIP modulates human breast cancer cell proliferation
por: Jiang, Yang, et al.
Publicado: (2018)

HBXIP knockdown inhibits FHL2 to promote cycle arrest and suppress cervical cancer cell proliferation, invasion and migration
por: Gao, Xia, et al.
Publicado: (2023)

Correlation between obesity and clinicopathological characteristics in patients with papillary thyroid cancer: a study of 1579 cases: a retrospective study
por: Wang, Huijuan, et al.
Publicado: (2020)

The SKA3-DUSP2 Axis Promotes Gastric Cancer Tumorigenesis and Epithelial-Mesenchymal Transition by Activating the MAPK/ERK Pathway
por: Zhang, Chao, et al.
Publicado: (2022)

Oncogenic HBXIP enhances ZEB1 through Sp1 to accelerate breast cancer growth
por: Jiang, Yang, et al.
Publicado: (2018)

HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis
por: Zhang, Lu, et al.
Publicado: (2023)

MAPK-ERK Pathway
por: Park, Jong-In
Publicado: (2023)

The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt–PCAF pathway in promotion of esophageal squamous cell carcinoma growth
por: Wu, Yue, et al.
Publicado: (2020)

HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer
por: Zhang, Shenghong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cgcimubb7u0lhqhegejavmbrhq